Safety And Efficacy Of Switching To Tenofovir Alafenamide (Taf) In Virally Suppressed Chronic Hepatitis B (Chb) Patients With Hepatic Impairment: Week 48 Results From A Phase 2 Open Label Study

AMERICAN JOURNAL OF GASTROENTEROLOGY(2020)

引用 5|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要